Andi Cani

[U-M Rogel Cancer Center @UMRogelCancer]

Postdoctoral fellow Andi Cani and team demonstrated the ability to detect precision medicine cancer genomic biomarkers and to monitor them over time by liquid biopsy using single-cell DNA sequencing of circulating tumor cells. Out now in @MolOncology: https://t.co/ofBirjyHst

[U-M Rogel Cancer Center @UMRogelCancer]

New paper from Andi Cani and @hoosierdfh lab published in @MolOncology finds serial monitoring of CTC genome can enable real-time tracking of tumor evolution during progression, which could help with precision medicine interventions: https://t.co/bMJCkvSV5P